An Update of Clinical CT Imaging of Pancreatic Neoplasm: Tips, Tricks, and Pitfalls

  • Ott LeEmail author
  • Eric P. Tamm
  • Nicolaus Wagner-Bartak
  • Priya Bhosale
  • Madhavi Patnana
  • Raghu Vikram
  • Aliya Qayyum
Abdominal CT-An Update on Applications and New Developments (H S. Teh, Section Editor)
Part of the following topical collections:
  1. Abdominal CT-An Update on Applications and New Developments


The progressive advancement in computed tomography (CT) technology has enabled improved diagnosis and management of pancreatic tumors. Some of these improvements are seen in multidetector CT, dual-energy CT, perfusion CT, and post-processing techniques. Despite the technological improvement, prognosis for tumors such as pancreatic adenocarcinomas remains dismal. This review article will discuss some of the tips, tricks, and pitfalls for optimal utilization of these imaging techniques to characterize, diagnosis, and manage some of the more common pancreatic tumors such as adenocarcinomas, cystic tumors, and neuroendocrine tumors.


MDCT DECT Perfusion CT Post-processing Pancreatic protocol Pancreatic cancer 



Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Levin DC, Rao VM, Parker L. The recent downturn in utilization of CT: the start of a new trend? J Am Coll Radiol. 2012;9(11):795–8.PubMedCrossRefGoogle Scholar
  2. 2.
    • Tamm EP, et al. Imaging of pancreatic ductal adenocarcinoma: state of the art. World J Radiol. 2013;5(3):98–105. Provides summary of current best available imaging modality for evaluation of pancreatic adenocarcinoma, such as MDCT, MRI, and PET/CT. Google Scholar
  3. 3.
    De La Cruz MSD, Young AR, Ruffin MT. Diagnosis and management of pancreatic cancer. Am Fam Physician. 2014;89(8):626–32.Google Scholar
  4. 4.
    Bashir MR, Gupta RT. MDCT evaluation of the pancreas: nuts and bolts. Radiol Clin North Am. 2012;50(3):365–77.PubMedCrossRefGoogle Scholar
  5. 5.
    •• Tempero MA, et al. Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2012;10(6):703–13. Discusses current guidelines in the workup and management of tumors of the exocrine pancreas. Google Scholar
  6. 6.
    Demos TC, et al. Cystic lesions of the pancreas. Am J Roentgenol. 2002;179(6):1375–88.CrossRefGoogle Scholar
  7. 7.
    Coursey CA, et al. Dual-energy multidetector CT: how does it work, what can it tell us, and when can we use it in abdominopelvic imaging? Radiographics. 2010;30(4):1037–55.PubMedCrossRefGoogle Scholar
  8. 8.
    Schima W, Kölblinger C, Ba-Ssalamah A, et al. MDCT of Pancreatic Tumors. In: Reiser MF, et al., editors. Multislice CT. Berlin Heidelberg: Springer; 2009. p. 407–22.CrossRefGoogle Scholar
  9. 9.
    Prokesch RW, et al. isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs. Radiology. 2002;224(3):764–8.PubMedCrossRefGoogle Scholar
  10. 10.
    • Lee, ES, Lee JM, Imaging diagnosis of pancreatic cancer: a state-of-the-art review. World J Gastroenterol. 2014;20(24):7864–77. Review of pancreatic cancer and the various advantages and disadvantages of the different imaging techniques, such as MDCT, MRI, MRCP, etc. Google Scholar
  11. 11.
    Callery MP, et al. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol. 2009;16(7):1727–33.PubMedCrossRefGoogle Scholar
  12. 12.
    Yanaga Y, et al. Pancreas: patient body weight tailored contrast material injection protocol versus fixed dose protocol at dynamic CT. Radiology. 2007;245(2):475–82.PubMedCrossRefGoogle Scholar
  13. 13.
    Kakihara D, et al. Usefulness of the long-axis and short-axis reformatted images of multidetector-row CT in evaluating T-factor of the surgically resected pancreaticobiliary malignancies. Eur J Radiol. 2007;63(1):96–104.PubMedCrossRefGoogle Scholar
  14. 14.
    Prokesch RW, et al. Local staging of pancreatic carcinoma with multi-detector row CT: use of curved planar reformations initial experience. Radiology. 2002;225(3):759–65.PubMedCrossRefGoogle Scholar
  15. 15.
    Prokesch RW, et al. Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs. Radiology. 2002;224(3):764–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Chu AJ, et al. Dual-source, dual-energy multidetector CT for the evaluation of pancreatic tumours. Br J Radiol. 1018;2012(85):e891–8.Google Scholar
  17. 17.
    Le Ott M, Bhosale P, Sklaruk J, Ng C, Tamm E. MDCT: impact of new technologies on oncologic imaging practical considerations. Appl Radiol. 2013;42(1):24–34.Google Scholar
  18. 18.
    Graser A, et al. Dual energy CT: preliminary observations and potential clinical applications in the abdomen. Eur Radiol. 2009;19(1):13–23.PubMedCrossRefGoogle Scholar
  19. 19.
    Macari M, et al. Dual-source dual-energy MDCT of pancreatic adenocarcinoma: initial observations with data generated at 80 kVp and at simulated weighted-average 120 kVp. Am J Roentgenol. 2010;194(1):W27–32.CrossRefGoogle Scholar
  20. 20.
    Zamboni GA, et al. Single-energy low-voltage arterial phase MDCT scanning increases conspicuity of adenocarcinoma of the pancreas. Eur J Radiol. 2014;83(3):e113–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Grozinger G, Grozinger A, Horger M. The role of volume perfusion CT in the diagnosis of pathologies of the pancreas. Rofo. 2014;186:1082–93.PubMedCrossRefGoogle Scholar
  22. 22.
    D’Onofrio M, et al. Perfusion CT can predict tumoral grading of pancreatic adenocarcinoma. Eur J Radiol. 2013;82(2):227–33.PubMedCrossRefGoogle Scholar
  23. 23.
    d’Assignies G, et al. Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology. 2009;250(2):407–16.PubMedCrossRefGoogle Scholar
  24. 24.
    Tsuji Y, Takahashi N, Tsutomu C. Pancreatic perfusion CT in early stage of severe acute pancreatitis. Int J Inflam. 2012;2012:497386.PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Watanabe T, et al. Relationship between pancreatic perfusion parameters and clinical complications of severe acute pancreatitis. Pancreas. 2013;42(1):180–2.PubMedCrossRefGoogle Scholar
  26. 26.
    Yoon SH, et al. Small (≤20 mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT. Radiology. 2011;259(2):442–52.PubMedCrossRefGoogle Scholar
  27. 27.
    • Del Gaizo AJS, Alvin C, Hara Amy K, The utility of dual-energy computed tomography in abdominal imaging. Appl Radiol. 2014;43(1):12–9. Summary of DECT technology application in abdominal imaging. Google Scholar
  28. 28.
    Kim JH, et al. Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology. 2010;257(1):87–96.PubMedCrossRefGoogle Scholar
  29. 29.
    Kim JH, et al. Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology. 2010;257(1):87–96.PubMedCrossRefGoogle Scholar
  30. 30.
    Coakley FV, et al. Pancreatic imaging mimics: part 1, imaging mimics of pancreatic adenocarcinoma. Am J Roentgenol. 2012;199(2):301–8.CrossRefGoogle Scholar
  31. 31.
  32. 32.
    Vargas R, et al. MDCT in pancreatic adenocarcinoma: prediction of vascular invasion and resectability using a multiphasic technique with curved planar reformations. Am J Roentgenol. 2004;182(2):419–25.CrossRefGoogle Scholar
  33. 33.
    Lee JK, et al. Prediction of vascular involvement and resectability by multidetector-row CT versus MR imaging with MR angiography in patients who underwent surgery for resection of pancreatic ductal adenocarcinoma. Eur J Radiol. 2010;73(2):310–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Robinson E, et al. Dual source dual energy MDCT: comparison of 80 kVp and weighted average 120 kVp data for conspicuity of hypo-vascular liver metastases. Invest Radiol. 2010;45(7):413–8.PubMedGoogle Scholar
  35. 35.
    Roche CJ, et al. CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas. Am J Roentgenol. 2003;180(2):475–80.CrossRefGoogle Scholar
  36. 36.
    Soriano A, et al. Preoperative staging and tumor resectability assessment of pancreatic cancer: Prospective Study Comparing Endoscopic Ultrasonography, Helical Computed Tomography, Magnetic Resonance Imaging, and Angiography. Am J Gastroenterol. 2004;99(3):492–501.PubMedCrossRefGoogle Scholar
  37. 37.
    Kawamoto S, et al. Pancreatic neuroendocrine tumor with cystlike changes: evaluation with MDCT. Am J Roentgenol. 2013;200(3):W283–90.CrossRefGoogle Scholar
  38. 38.
    Gallotti A, et al. Incidental neuroendocrine tumors of the pancreas: mDCT findings and features of malignancy. Am J Roentgenol. 2013;200(2):355–62.CrossRefGoogle Scholar
  39. 39.
    Foti G, et al. Preoperative assessment of nonfunctioning pancreatic endocrine tumours: role of MDCT and MRI. Radiol Med. 2013;118(7):1082–101.PubMedCrossRefGoogle Scholar
  40. 40.
    Marin D, et al. State of the Art: dual-Energy CT of the Abdomen. Radiology. 2014;271(2):327–42.PubMedCrossRefGoogle Scholar
  41. 41.
    Marin D, et al. Detection of pancreatic tumors, image quality, and radiation dose during the pancreatic parenchymal phase: effect of a low-tube-voltage, high-tube-current CT technique–preliminary results. Radiology. 2010;256(2):450–9.PubMedCrossRefGoogle Scholar
  42. 42.
    Lv P, et al. Spectral CT in patients with small HCC: investigation of image quality and diagnostic accuracy. Eur Radiol. 2012;22(10):2117–24.PubMedCrossRefGoogle Scholar
  43. 43.
    •• Tanaka M, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12(3):183–97. Summary of the latest consensus on the management of cystic tumors of the pancreas, such as recommend followup intervals. Google Scholar
  44. 44.
    Zaheer A, et al. Incidentally detected cystic lesions of the pancreas on CT: review of literature and management suggestions. Abdom Imaging. 2013;38(2):331–41.PubMedCrossRefGoogle Scholar
  45. 45.
    Chalian H, et al. CT attenuation of unilocular pancreatic cystic lesions to differentiate pseudocysts from mucin-containing cysts. JOP. 2011;12(4):384–8.PubMedGoogle Scholar
  46. 46.
    Pongpornsup S, Piyapittayanan S, Charoensak A. MDCT imaging findings for characterization pancreatic cystic lesion: differentiation between benign and malignant pattern. J Med Assoc Thai. 2011;94(3):369–78.PubMedGoogle Scholar
  47. 47.
    Edirimanne S, Connor SJ. Incidental pancreatic cystic lesions. World J Surg. 2008;32(9):2028–37.PubMedCrossRefGoogle Scholar
  48. 48.
    Itoh S, et al. Assessment of the pancreatic and intrapancreatic bile ducts using 0.5-mm collimation and multiplanar reformatted images in multislice CT. Eur Radiol. 2003;13(2):277–85.PubMedGoogle Scholar
  49. 49.
    Fukushima H, et al. Diagnostic value of curved multiplanar reformatted images in multislice CT for the detection of resectable pancreatic ductal adenocarcinoma. Eur Radiol. 2006;16(8):1709–18.PubMedCrossRefGoogle Scholar
  50. 50.
    Tamm EP, et al. Update on 3D and multiplanar MDCT in the assessment of biliary and pancreatic pathology. Abdom Imaging. 2009;34(1):64–74.PubMedCrossRefGoogle Scholar
  51. 51.
    Tseng JF. Management of serous cystadenoma of the pancreas. J Gastrointest Surg. 2008;12(3):408–10.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Ott Le
    • 1
    Email author
  • Eric P. Tamm
    • 1
  • Nicolaus Wagner-Bartak
    • 1
  • Priya Bhosale
    • 1
  • Madhavi Patnana
    • 1
  • Raghu Vikram
    • 1
  • Aliya Qayyum
    • 1
  1. 1.University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations